Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients

Norwegian University of Science and Technology18 enrolled

Overview

The primary objective is to establish the safety of the CO-rebreathing method for measuring total blood and plasma volume in CAD patients. The working hypothesis is that the CO-rebreathing method is safe in use with coronary artery disease patients and that it does not cause myocardial ischemia or cardiovascular damage.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Cardiovascular Disease Chronic Obstructive Pulmonary Disease

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Stable coronary artery disease * Stable COPD * Optimal medication Exclusion Criteria: * Unstable disease * co-morbidities

Locations (1)

Norwegian University of Science and Technology

Trondheim, Norway

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.